India Stands Firm in US Trade Talks Amidst Tariff Challenges

India remains unaffected by the 25% US tariff due to existing exemptions. Over half of Indian exports, particularly in pharma and electronics, face no new duties. India maintains its stance on not granting duty exemptions in agricultural and dairy sectors, preserving sentiment-driven policies amidst ongoing US trade negotiations.

India remains largely unaffected by the recent imposition of a 25% US tariff, as most of its exports to the United States, including pharmaceuticals and electronics, are already exempt from such duties, according to official sources.

While a small portion of India's USD 131.8 billion bilateral trade with the US will be impacted, the majority of goods exported will continue without increased tariffs. Exports estimated to be vulnerable to the new tariffs amount to approximately USD 40 billion.

The Indian government has strongly opposed granting any duty exemptions on agricultural, dairy, or genetically modified products, citing the need to uphold religious sentiments and previous trade pact commitments. Despite ongoing trade negotiations with the US, India remains steadfast in its policy decisions.

(With inputs from agencies.)